PFIZER INC reported revenue of $15.03B for the period ended 2026-06-28, +2.6% year on year. Net income was $-0.25B, a -1.6% net margin on a 100.0% gross margin. The largest revenue line is U.S.Commercial Division at 53% of the total. Free cash flow for the period was $0.30B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $15.03B | +2.6% |
| Gross profit | $15.03B | — |
| Operating income | $-0.65B | — |
| Net income | $-0.25B | -108.5% |
| Gross margin | 100.0% | Net margin -1.6% |
| Revenue Q/Q | +4.0% | — |
| Segment | Revenue | Share |
|---|---|---|
| U.S.Commercial Division | $7.96B | 52.9% |
| International Commercial Division | $5.54B | 36.9% |
| Global Hospital And Biosimilars Division | $1.16B | 7.7% |
| Item | Amount | % of revenue |
|---|---|---|
| SG&A | $3.41B | 22.7% |
| Tax & other | $-0.41B | -2.7% |
| Item | Amount |
|---|---|
| Total assets | $201.13B |
| Total liabilities | $115.64B |
| Shareholders' equity | $85.49B |
| Equity / assets | 42.5% |
| Operating cash flow | $0.83B |
| Capital expenditure | $0.53B |
| Free cash flow | $0.30B |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
PCG ・ PM ・ PSX ・ PNW ・ PNC ・ PPG ・ PPL ・ PFG ・ PG ・ PGR ・ PLD ・ PRU
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies